-
Logout
Our Mission
Advancing Cancer Diagnostics, Improving Lives
Our Vision
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Leica Biosystems Expands Research Digital Pathology Portfolio with Launch of the compact Aperio CS5 Scanner
VISTA, California, January 27, 2026 – Leica Biosystems, a Danaher company and global leader in anatomic and digital pathology solutions, announces the launch of the Aperio CS5 scanner, a compact device designed to support digital transformation in research pathology.
Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems
Indica Labs’ HALO AP Dx digital pathology platform for primary diagnostics has received FDA 510(k) clearance with Leica Biosystems’ Aperio GT 450 DX Scanner and is cleared for use with both SVS and DICOM file formats
Leica Biosystems Expands Leading Digital Pathology Portfolio for the US with Multiple Launches at Pathology Visions 2025
In a groundbreaking showcase of innovation designed to accelerate the digital transformation of pathology, Leica Biosystems proudly launches its latest, pioneering software solutions in the Aperio Digital Pathology portfolio at booth #313 during Pathology Visions.
Leica Biosystems at a Glance
150+ Years of Innovation
| 2012 - Present | New Era of Science & Technology |
| 2005 - 2011 | Global Expansion Accelerates |
| 1989 - 2004 | Structuring for Comprehensive Workflow |
| 1930 - 1988 | Novel Products Drive Company Growth |
| 1900 - 1930 | Microtomy Technology Advances Amidst Wartime Realities |
| 1872 - 1899 | The Creation of the Microtome and the Early Years of R. Jung GMBH |
About Danaher
Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.